Management of Dyspnea with Ambulation
Initial Diagnostic Approach
- The American College of Radiology suggests that the evaluation must identify the underlying cause since dyspnea on exertion commonly indicates cardiac or pulmonary disease 1
- First-line diagnostic tests include complete blood count and basic metabolic panel to assess for anemia, electrolyte abnormalities, and renal dysfunction, as recommended by the American College of Cardiology 2
- Chest radiography is used to identify pulmonary pathology, pleural effusions, or cardiac enlargement, according to the American College of Radiology 2
- Electrocardiography is used to detect arrhythmias, ischemia, or conduction abnormalities, as suggested by the American College of Cardiology 1
- Physical examination findings to assess include cardiac murmurs, extra heart sounds, or irregular rhythm, as recommended by the American College of Cardiology 1
- Peripheral edema indicating heart failure should be assessed, according to the American College of Cardiology 1
Treatment of Underlying Causes
- The American College of Cardiology recommends optimizing heart failure medications, including diuretics for fluid overload, to treat cardiac causes of dyspnea 3, 2
- The American Heart Association suggests addressing valvular heart disease through appropriate interventions 1
- The American College of Chest Physicians recommends treating arrhythmias and ischemic disease 1
- The National Comprehensive Cancer Network suggests using bronchodilators for obstructive airway disease, steroids for inflammatory conditions, and antibiotics for infectious processes to treat pulmonary causes of dyspnea 3
- The American Thoracic Society recommends considering anti-inflammatory or antifibrotic therapy for interstitial lung disease 2
Non-Pharmacological Interventions
- The American College of Physicians recommends implementing non-pharmacological interventions, such as cool air directed at the face, optimal positioning, and cooler room temperatures, to provide immediate comfort measures 4, 5, 6, 7
- The European Respiratory Society suggests using pulmonary rehabilitation and exercise training programs to decrease dyspnea intensity 4, 2
- The American Thoracic Society recommends using walking aids or frames to reduce respiratory muscle demand during ambulation 5, 6, 7
- The American College of Chest Physicians suggests using respiratory training and breathing techniques to improve symptom management 5, 6, 7
Pharmacological Management
- The European Society for Medical Oncology recommends using opioids as first-line symptomatic treatment for dyspnea, with dosing for opioid-naïve patients starting at 2.5-10 mg PO every 2-4 hours as needed 5, 6, 7
- The American College of Cardiology suggests increasing the dose by 25% for breakthrough dyspnea in patients already on chronic opioids 3
- The American Academy of Hospice and Palliative Medicine recommends avoiding morphine in severe renal insufficiency and adjusting dosing intervals based on renal function 7
- The National Comprehensive Cancer Network suggests using adjunctive benzodiazepines, such as lorazepam, when opioids provide insufficient relief 7, 2
- The American Thoracic Society recommends using oxygen therapy only for symptomatic hypoxia or when subjective relief is reported 3, 7
Advanced Interventions
- The American College of Chest Physicians recommends considering noninvasive positive-pressure ventilation (CPAP, BiPAP) for severe reversible conditions 3
- The American Academy of Hospice and Palliative Medicine suggests using terminal sedation with benzodiazepines in addition to opioids for refractory dyspnea in dying patients 7
- The National Comprehensive Cancer Network recommends palliative care consultation for symptom management in patients with limited life expectancy 2
Diagnosis and Treatment of Dyspnea on Exertion
Diagnostic Evaluation
- Brain natriuretic peptide (BNP) testing has a cut point of >100 pg/mL with 96% sensitivity for heart failure in patients with dyspnea, according to the American College of Emergency Physicians 8
Treatment of Pulmonary Causes
- In patients over 50 years old with chronic breathlessness, assume COPD until proven otherwise and initiate bronchodilator therapy, with a target oxygen saturation of 88-92% if hypoxemic, as recommended by the European Respiratory Society 9
- Use 28% Venturi mask or 1-2 L/min nasal cannula rather than high-flow oxygen in suspected COPD patients to avoid CO2 retention, as suggested by the British Thoracic Society 9